Valeant buys stake in Brazilian pharma; FTC leans toward approval of Express-Medco deal;

@FiercePharma: Sanofi launched a gadget that lets diabetes patients check their blood sugar on iPhones and iPads. News $SNY #pharma | Follow @FiercePharma

> Acquisition-hungry Valeant Pharmaceuticals ($VRX) snapped up a 19.9% stake in Brazil's Pele Nova, gaining a toehold in that country and adding a share of the company's skin business to its growing dermatology channel. Report

> The Federal Trade Commission appears less likely to nix the proposed merger of pharmacy benefits managers Medco Health Solutions ($MHS) and Express Scripts ($ESRX). News

> As Vertex Pharmaceuticals ($VRTX) prepares to leave Cambridge, MA, for digs elsewhere in the Boston area, a real estate investor is eyeing new housing for part of the drugmaker's former site. Story

> County officials in North Carolina are rethinking incentive payments to Pfizer ($PFE) as the company slashes its head count at a local vaccine facility. Article

> Time is running out for non-profit organizations to apply for one of GlaxoSmithKline's ($GSK) $40,000 Impact Awards, aimed at improving access to healthcare. Report

> India's Biocon has established API partnerships for an assault on the U.S. market for generic Lipitor, executives say. More

Biotech News

@FierceBiotech: Disappointing cancer data triggers sharp drop in Peregrine $PPHM shares. Story  | Follow @FierceBiotech

@JohnCFierce:  Pretty grim morning for biotech. 2 trial disasters and a near bankruptcy. But, hey, HemaQuest raised $13M. Release | Follow @JohnCFierce

@RyanMFierce: LSD gets another look as anti-alcoholism remedy. Report | Follow @RyanMFierce

@FierceMedDev: NY Times: Asahi Kasei of Japan Agrees to Buy Zoll Medical for $2.2 Billion. Story | Follow @FierceMedDev

> Tranzyme shares implode as lead GI drug flunks its PhIII closeup. Item

> Pfizer spearheads push to get pain drugs back on blockbuster track. Report

> Bionovo slashes bulk of staff, cuts costs as cash runs out. Story

> HemaQuest nails $13M VC extension for sickle cell program. News

> Disappointing cancer data triggers sharp drop in Peregrine shares. Story

> Anthera shares collapse on halt of Phase III cardio trial. Item

Medical Device News

>  Doctors in limbo over recalled St. Jude defib lead. Item

> UnitedHealth lobbies for molecular Dx management. Report

> LensAR raises $24M to back laser system. Story

> Asahi Kasei scoops up Zoll for $2.2B, reflecting Japanese companies' hunger for growth. Item

>  BSX grabs ICD startup Cameron Health for $150M+. Report

> Genetic sequencing price tag plunging. News

Biotech IT News

> What IT services do biopharma execs really want? More

> Google VC-backed startup plays 'Moneyball' in Big Pharma partnerships. Report

> Medidata projects big year, settles lawsuit. Story

> Accelrys stays on growth track in Q4. News

And Finally... U.K. scientists are testing a combination of two off-patent drugs, including the antidepressant tranylcypromine, as a treatment for acute myeloid leukemia. Report